The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma ModelsKatie E. Hebron, Marielle E. Yohe, Jacob S. Roth et al.|Clinical Cancer Research|2022Cited by 21